DWAS - ETF AI Analysis
Top Page
Invesco DWA SmallCap Momentum ETF (DWAS)
Rating:62Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown solid gains over the past three and twelve months, indicating positive recent momentum in its strategy.
Momentum-Focused Small-Cap Strategy
Many of the top holdings have delivered strong year-to-date gains, reflecting the fund’s focus on small companies with improving stock trends.
Meaningful Asset Base
With several hundred million dollars in assets, the fund is large enough to suggest steady investor interest and operational stability.
Negative Factors
High Expense Ratio
The fund’s fees are relatively high for an ETF, which can eat into long-term returns compared with lower-cost options.
Heavy Health Care Concentration
A large portion of the portfolio is in health care stocks, increasing the risk that sector-specific setbacks could hurt overall performance.
U.S.-Only Exposure
Almost all holdings are in U.S. companies, offering little geographic diversification if the U.S. market faces a downturn.
DWAS vs. SPDR S&P 500 ETF (SPY)
AUM356.41M
RegionNorth America
Expense Ratio0.60%
Beta1.23
IssuerInvesco
Inception DateJul 19, 2012
Dividend Yield0.15%
Asset ClassEquity
Index TrackedDorsey Wright SmallCap Tech Leaders Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume8,855
30 Day Avg. Volume81,617
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
133.75Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering200
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DWAS Summary
The Invesco DWA SmallCap Momentum ETF (DWAS) tracks the Dorsey Wright SmallCap Technical Leaders Index, which focuses on smaller U.S. companies whose stock prices have been rising strongly. It holds a wide mix of sectors, with a big tilt toward health care and industrials, and includes lesser-known names like Bel Fuse and Planet Labs. Someone might invest in DWAS if they want growth potential from small, fast-moving companies and diversification away from large, well-known stocks. A key risk is that small-cap momentum stocks can be very volatile and may fall quickly when market conditions change.
How much will it cost me?The Invesco DWA SmallCap Momentum ETF (DWAS) has an expense ratio of 0.6%, meaning you’ll pay $6 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on small-cap stocks with strong momentum, which requires more research and management compared to passively managed ETFs. It’s designed for investors seeking growth opportunities in dynamic, smaller companies.
What would affect this ETF?The DWAS ETF, focused on U.S. small-cap stocks with strong momentum, could benefit from economic growth and innovation in sectors like Health Care and Technology, which make up a significant portion of its holdings. However, it may face challenges during periods of economic uncertainty or rising interest rates, which can negatively impact small-cap companies and momentum-driven strategies. Regulatory changes or sector-specific headwinds could also influence the performance of its top holdings.
DWAS Top 10 Holdings
DWAS is leaning hard into U.S. small-cap momentum, with a big tilt toward health care and other growthy niches. High-flyers like Planet Labs and Lumentum have been doing the heavy lifting, riding strong recent gains and giving the fund much of its spark. Industrial name Bel Fuse and payments player Sezzle are more steady contributors, adding support without stealing the spotlight. On the flip side, biotech bets like Nuvalent and Kodiak Sciences are lagging, acting as a bit of a speed bump for an otherwise fast-moving, domestically focused portfolio.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Planet Labs PBC | 2.30% | $8.01M | $11.46B | 792.61% | 57 Neutral | |
| Terns Pharmaceuticals | 1.98% | $6.90M | $5.15B | 1345.97% | 45 Neutral | |
| Bel Fuse Inc | 1.82% | $6.35M | $2.55B | 177.48% | 73 Outperform | |
| Lumentum Holdings | 1.55% | $5.40M | $50.43B | 960.43% | 61 Neutral | |
| Sezzle Inc. | 1.53% | $5.32M | $2.24B | 68.23% | 80 Outperform | |
| Tutor Perini | 1.50% | $5.22M | $3.66B | 182.67% | 65 Neutral | |
| Graham | 1.43% | $4.97M | $885.05M | 158.92% | 69 Neutral | |
| Celcuity | 1.42% | $4.94M | $4.91B | 909.90% | 44 Neutral | |
| Nuvalent | 1.28% | $4.46M | $7.45B | 21.56% | 43 Neutral | |
| Kodiak Sciences | 1.25% | $4.34M | $1.36B | 578.35% | 35 Underperform |
DWAS Technical Analysis
Negative
―
Price Trends
100.69
Negative
98.14
Negative
93.01
Positive
Market Momentum
-1.43
Positive
38.53
Neutral
17.90
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DWAS, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 99.54, equal to the 50-day MA of 100.69, and equal to the 200-day MA of 93.01, indicating a neutral trend. The MACD of -1.43 indicates Positive momentum. The RSI at 38.53 is Neutral, neither overbought nor oversold. The STOCH value of 17.90 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DWAS.
DWAS Peer Comparison
Comparison Results
Performance Comparison
DWAS
Invesco DWA SmallCap Momentum ETF
94.74
12.28
14.89%
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
―
―
―
GSSC
Goldman Sachs Activebeta U.S. Small Cap Equity ETF
―
―
―
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
―
―
―
JHSC
John Hancock Multifactor Small Cap ETF
―
―
―
SFLO
VictoryShares Small Cap Free Cash Flow ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents